کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1928143 | 1050315 | 2015 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b](/preview/png/1928143.png)
• miR-125b is down-regulated in ovarian cancer tissues and cells.
• PPARγ upregulates miR-125b and downregulates its target gene BCL3 expression.
• Silence of miR-125b attenuates PPARγ-mediated growth suppression of ovarian cancer cells.
• PPARγ promotes the transcription of miR-125b via binding to PPARE in miR-125b gene promoter region.
miR-125b has essential roles in coordinating tumor proliferation, angiogenesis, invasiveness, metastasis and chemotherapy recurrence. In ovarian cancer miR-125b has been shown to be downregulated and acts as a tumor suppressor by targeting proto-oncogene BCL3. PPARγ, a multiple functional transcription factor, has been reported to have anti-tumor effects through inhibition of proliferation and induction of differentiation and apoptosis by targeting the tumor related genes. However, it is unclear whether miR-125b is regulated by PPARγ in ovarian cancer. In this study, we demonstrated that the miR-125b downregulated in ovarian cancer tissues and cell lines. Ligands-activated PPARγ suppressed proliferation of ovarian cancer cells and this PPARγ-induced growth inhibition is mediated by the upregulation of miR-125b. PPARγ promoted the expression of miR-125b by directly binding to the responsive element in miR-125b gene promoter region. Thus, our results suggest that PPARγ can induce growth suppression of ovarian cancer by upregulating miR-125b which inhibition of proto-oncogene BCL3. These findings will extend our understanding of the function of PPARγ in tumorigenesis and miR-125b may be a therapeutic intervention of ovarian cancer.
Journal: Biochemical and Biophysical Research Communications - Volume 462, Issue 2, 26 June 2015, Pages 85–90